References
- Romanelli RMC, de Souza GG, Fontis JP, Rodrigues JHP, Viana JPR, Rocha KO, et al. Risk factors for colonization/infection by resistant microorganisms in outbreaks in neonatal unit-a systematic review and meta-analysis. J Pediatr (Rio J). 2025;101:297–311.
- Kappstein I, Schulgen G, Beyer U, Geiger K, Schumacher M, Daschner FD. Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis. 1992;11:504–8.
- Heffernan AJ, Sime FB, Lipman J, Dhanani J, Andrews K, Ellwood D, et al. Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic review. Int J Antimicrob Agents. 2019;53:234–45.
- Panidis D, Markantonis SL, Boutzouka E, Karatzas S, Baltopoulos G. Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia. Chest. 2005;128:545–52.
- Imberti R. Intravenous colistimethate administration and colistin lung tissue concentrations. Intensive Care Med. 2010;36:1795.
- Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.
- Stass H, Corkery K, Gribben D, Eldon MA. Pharmacokinetics and tolerability of BAY41-6551 in subjects with chronic kidney disease. J Aerosol Med Pulm Drug Deliv. 2011;24:191–9.
- Ehrmann S, Barbier F, Li J. Aerosolized Antibiotic Therapy in Mechanically Ventilated Patients. Am J Respir Crit Care Med. 2024;210:730–6.
- Maselli DJ, Keyt H, Restrepo MI. Inhaled Antibiotic Therapy in Chronic Respiratory Diseases. Int J Mol Sci. 2017;18.
- Liu D, Zhang J, Liu HX, Zhu YG, Qu JM. Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis. Int J Antimicrob Agents. 2015;46:603–9.
- Qin JP, Huang HB, Zhou H, Zhu Y, Xu Y, Du B. Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials. Sci Rep. 2021;11:6969.
- Rivetti S, Romano A, Mastrangelo S, Attinà G, Maurizi P, Ruggiero A. Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients. Pharmaceuticals (Basel). 2023;16.
- McWilliam SJ, Antoine DJ, Smyth RL, Pirmohamed M. Aminoglycoside-induced nephrotoxicity in children. Pediatr Nephrol. 2017;32:2015–25.
- Gallucci M, di Palmo E, Bertelli L, Camela F, Ricci G, Pession A. A pediatric disease to keep in mind: diagnostic tools and management of bronchiectasis in pediatric age. Ital J Pediatr. 2017;43:117.
- Solé-Lleonart C, Rouby JJ, Blot S, Poulakou G, Chastre J, Palmer LB, et al. Nebulization of Antiinfective Agents in Invasively Mechanically Ventilated Adults: A Systematic Review and Meta-analysis. Anesthesiology. 2017;126:890–908.
- Zhang X, Cui X, Jiang M, Huang S, Yang M. Nebulized colistin as the adjunctive treatment for ventilator-associated pneumonia: A systematic review and meta-analysis. J Crit Care. 2023;77:154315.
- Ehrmann S, Barbier F, Demiselle J, Quenot JP, Herbrecht JE, Roux D, et al. Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia. N Engl J Med. 2023;389:2052–62.
- Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63:e61–e111.
- Rello J, Solé-Lleonart C, Rouby JJ, Chastre J, Blot S, Poulakou G, et al. Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect. 2017;23:629–39.
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372.
- Pearce H, Talks BJ, Powell S, Brodlie M, Powell J. A systematic review of antimicrobial therapy in children with tracheostomies. Pediatric Pulmonology. 2023.
- Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. The lancet. 2007;370:1453–7.
- Vandenbroucke JP, Elm Ev, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Annals of internal medicine. 2007;147:W-163–W-94.
- Higgins JP, Savović J, Page MJ, Elbers RG, Sterne JA. Assessing risk of bias in a randomized trial. Cochrane handbook for systematic reviews of interventions. 2019:205–28.
- Inhaled Colistin to Prevent Pediatric Ventilator-associated Pneumonia: A Double Blind Multicenter Randomized Controlled Trial Protocol [Internet]. 2024. Available from:
https://clinicaltrials.gov/study/NCT06488794 . - Levchenko B, Nazarchuk O, Dmytriiev D, Bahniuk N, Melnychenko M, Dmytriiev K. Adjunctive inhaled amikacin in infants with Ventilator-Associated Pneumonia optimizes the complex antimicrobial therapy: pilot study. Acta Bio-medica: Atenei Parmensis. 2023;94:e2023084-e.
- Polat M, Kara SS, Tapisiz A, Tezer H, Kalkan G, Dolgun A. Treatment of Ventilator-Associated Pneumonia Using Intravenous Colistin Alone or in Combination with Inhaled Colistin in Critically Ill Children. Pediatric Drugs. 2015;17:323–30.
- Hussain K, Salat MS, Ambreen G, Mughal A, Idrees S, Sohail M, et al. Intravenous vs intravenous plus aerosolized colistin for treatment of ventilator-associated pneumonia - a matched case-control study in neonates. Expert Opinion on Drug Safety. 2020;19:1641–9.
- Khanbabaee G MJM, Behzad A, Hashemi S M, Ahmadizadeh S N, et al. Efficacy of Inhaled Colistin in Critically Ill Children with Ventilator-Associated Pneumonia Resistant to Multiple Drugs. J Compr Ped. 2024;15:e151869.
- Bharathi KS, Bhat A, Pruthi G, Simha PP. Randomized control study of nebulized colistin as an adjunctive therapy in ventilator-associated pneumonia in pediatric postoperative cardiac surgical population. Annals of cardiac anaesthesia. 2022;25:435–40.
- Anil Sachdev NKS, Dhiren Gupta, Neeraj Gupta, Suresh Gupta. Efficacy of Adjuvant Colistimethate Sodium Nebulization in Ventilator Associated Pneumonia in Pediatric Intensive Care Unit - A Randomized Controlled Study. J Pediatr Crit Care. 2019;6:15.
- Kang CH, Tsai CM, Wu TH, Wu HY, Chung MY, Chen CC, et al. Colistin inhalation monotherapy for ventilator-associated pneumonia of Acinetobacter baumannii in prematurity. Pediatr Pulmonol. 2014;49:381–8.
- Kang CH, Tsai CM, Wu TH, Wu HY, Chung MY, Chen CC, et al. Colistin inhalation monotherapy for ventilator-associated pneumonia of Acinetobacter baumannii in prematurity. Pediatric pulmonology. 2014;49:381–8.
- Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med. 2005;33:1266–71.
- Alshaikh R, AlKhalifah A, Fayed A, AlYousef S. Factors influencing the length of stay among patients admitted to a tertiary pediatric intensive care unit in Saudi Arabia. Front Pediatr. 2022;10:1093160.
- Arafah YF, Murni IK, Rusmawatiningtyas D. Predictors of prolonged stay in the pediatric intensive care unit. Paediatrica Indonesiana. 2020;60:37–41.
- Zampieri FG, Nassar AP, Jr., Gusmao-Flores D, Taniguchi LU, Torres A, Ranzani OT. Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis. Crit Care. 2015;19:150.
- Osuagwu UL, Xu M, Piya MK, Agho KE, Simmons D. Factors associated with long intensive care unit (ICU) admission among inpatients with and without diabetes in South Western Sydney public hospitals using the New South Wales admission patient data collection (2014–2017). BMC Endocr Disord. 2022;22:27.
- Atoui R, Ma F, Langlois Y, Morin JF. Risk factors for prolonged stay in the intensive care unit and on the ward after cardiac surgery. J Card Surg. 2008;23:99–106.
- Sella N, Pettenuzzo T, De Cassai A, Zarantonello F, Congedi S, Bruni A, et al. Inhaled antibiotics for treating pneumonia in invasively ventilated patients in intensive care unit: a meta-analysis of randomized clinical trials with trial sequential analysis. Critical Care. 2024;28:387.
- Valachis A, Samonis G, Kofteridis DP. The role of aerosolized colistin in the treatment of ventilator-associated pneumonia: a systematic review and meta-analysis. Crit Care Med. 2015;43:527–33.
- Vardakas KZ, Mavroudis AD, Georgiou M, Falagas ME. Intravenous plus inhaled versus intravenous colistin monotherapy for lower respiratory tract infections: A systematic review and meta-analysis. Journal of Infection. 2018;76:321–7.
- Li J, Lyu S, Luo J, Liu P, Albuainain FA, Alamoudi OA, et al. Prophylactic Antibiotics Delivered Via the Respiratory Tract to Reduce Ventilator-Associated Pneumonia: A Systematic Review, Network Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials. Crit Care Med. 2024;52:1612–23.
- Chibabhai V, Bekker A, Black M, Demopoulos D, Dramowski A, du Plessis NM, et al. Appropriate use of colistin in neonates, infants and children: Interim guidance. Southern African Journal of Infectious Diseases. 2023;38.
- Government of Western Australia Child and Adolescent Health Service. Available from:
https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Monographs . - Alothman GA, Ho B, Alsaadi MM, Ho SL, O’Drowsky L, Louca E, et al. Bronchial constriction and inhaled colistin in cystic fibrosis. Chest. 2005;127:522–9.
- Gibson RL, Emerson J, McNamara S, Burns JL, Rosenfeld M, Yunker A, et al. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am J Respir Crit Care Med. 2003;167:841–9.
- Alothman GA, Alsaadi MM, Ho BL, Ho SL, Dupuis A, Corey M, et al. Evaluation of bronchial constriction in children with cystic fibrosis after inhaling two different preparations of tobramycin. Chest. 2002;122:930–4.
- Sadyrbaeva-Dolgova S, García-Fumero R, Exposito-Ruiz M, Pasquau-Liaño J, Jiménez-Morales A, Hidalgo-Tenorio C. Incidence of nephrotoxicity associated with intravenous colistimethate sodium administration for the treatment of multidrug-resistant gram-negative bacterial infections. Scientific Reports. 2022;12:15261.
- Nakwan N, Lertpichaluk P, Chokephaibulkit K, Villani P, Regazzi M, Imberti R. Pulmonary and Systemic Pharmacokinetics of Colistin Following a Single Dose of Nebulized Colistimethate in Mechanically Ventilated Neonates. Pediatric Infectious Disease Journal. 2015;34:961–3.
- Celik İH, Oguz SS, Demirel G, Erdeve O, Dilmen U. Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review. European Journal of Pediatrics. 2012;171:311–6.
- Nakwan N, Wannaro J, Thongmak T, Pornladnum P, Saksawad R, Nakwan N, et al. Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter Baumannii with aerosolized colistin in neonates: A preliminary report. Pediatric Pulmonology. 2011;46:60–6.
- Choudhry S, Ahmad E, Batool A, Raja N. Use of colistin for the treatment of multi drug resistant isolates in neonates. J Pak Med Assoc. 2017;67:1157–60.
- Barrowcliffe MP JJ. Solute permeability of the alveolar capillary barrier. . Thorax. 1987;42:1–10.
- Bal ZS, Can FK, Yazici P, Anil AB, Duyu M, Ciftdogan DY, et al. The evaluation of safety and efficacy of colistin use in pediatric intensive care unit: Results from two reference hospitals and review of literature. Journal of Infection and Chemotherapy. 2018;24:370–5.
- Hassan NA, Awdallah FF, Abbassi MM, Sabry NA. Nebulized Versus IV Amikacin as Adjunctive Antibiotic for Hospital and Ventilator-Acquired Pneumonia Postcardiac Surgeries: A Randomized Controlled Trial. Crit Care Med. 2018;46:45–52.
- Aggarwal R, Dewan A. Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study. Annals of clinical microbiology and antimicrobials. 2018;17:1–8.
- DeRyke CA, Crawford AJ, Uddin N, Wallace MR. Colistin dosing and nephrotoxicity in a large community teaching hospital. Antimicrobial agents and chemotherapy. 2010;54:4503–5.
- Waters V, Smyth A. Cystic fibrosis microbiology: Advances in antimicrobial therapy. J Cyst Fibros. 2015;14:551–60.
- Jutras C, Autmizguine J, Chomton M, Marquis C, Nguyen TT, Roumeliotis N, et al. Inhaled Antibiotics for the Prevention of Respiratory Tract Infections in Children With a Tracheostomy. Front Pediatr. 2021;9:633039.
- Cordeiro R, Choi H, Haworth CS, Chalmers JD. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: Updated systematic review and meta-analysis. Chest. 2024.
- Palmer LB, Smaldone GC. Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit. American journal of respiratory and critical care medicine. 2014;189:1225–33.
- Gowda AA, Cuccia AD, Smaldone GC. Reliability of Vibrating Mesh Technology. Respir Care. 2017;62:65–9.